EVALUATION FOR YOUNG CHILDREN WITH AUTISM SPECTRUM DISORDERS
NCT ID: NCT06867783
Last Updated: 2025-03-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
29 participants
INTERVENTIONAL
2024-11-29
2029-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Early Detection and Referral for Autism and Neurodevelopmental Disorders at the Maternal and Child Protection Services
NCT05815095
Early Screening of Autism Spectrum Disorder in General and Pediatric Practices
NCT04274127
Telepsychiatry in Children: Diagnostic Evaluation of Autism Spectrum Disorder
NCT06622395
Interactive Guidance Therapy With Video Feed-back of Parent and Child With Autism Spectrum Disorder
NCT04607616
Efficiency of Early Intervention for Autism Spectrum Disorder
NCT02608333
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Our objective is to evaluate quantitatively and qualitatively the collaborative family support system for ASD "Coquille". This scheme combines the development of a personalized care project based on parents' priorities, an intensive single-family parent-child follow-up and a group of multi-family therapy , over a total period of 6 months. Our main hypothesis is the significant decrease in behavioral disorders of children, evaluated by CARS, following the Coquille device. Our secondary hypotheses concern the evolution of parental dimensions following the device (sense of coherence, parental skills, parental stress, coping strategies and social support). We assume that these dimensions will change as a result of the scheme, and that they will be maintained in the medium term, six months after Coquille. A semi-structured interview will qualitatively explore the dimensions related to family resources, before and after the follow-up and in the medium term. This will also allow the mother to collect experience of the device.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
This six-month therapeutic device in day hospital includes:
* 22 TMF sessions,
* four two-family observation sessions,
* three sessions of four unique family sessions,
* the possibilities of individual targeted intervention in case of need estimated by families and/or caregivers.
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
coquille device
collaborative family support scheme aimed at improving family functioning and child behaviour
coquille
Modalities: Elaboration of the personalized care project, follow-up parents-child single family, multi-family therapy (MFT).
Frequency: MFT weekly, bi-familial observation weekly for one month, single-parent child-parent monitoring weekly for five months, MFT father-child bimonthly for six months, three co-parents, three child psychiatric consultations to develop the personalized collaborative care project
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
coquille
Modalities: Elaboration of the personalized care project, follow-up parents-child single family, multi-family therapy (MFT).
Frequency: MFT weekly, bi-familial observation weekly for one month, single-parent child-parent monitoring weekly for five months, MFT father-child bimonthly for six months, three co-parents, three child psychiatric consultations to develop the personalized collaborative care project
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* French language spoken and written by the parent
* Free and informed consent form , initialled and signed by the parent
* Child under 30 months of age at time of inclusion, diagnosed with autism spectrum disorder
* Total CARS score greater than or equal to 30
* Free and informed consent form, initialled and signed by legal representatives
Exclusion Criteria
* Current engagement in an interventional research protocol
* Mother under protection of justice, guardianship or enhanced curatorship
* Mother no longer having parental authority
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre hospitalier de Ville-Evrard, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Pierre LECARPENTIER
MBBS, psychiatrist and investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pierre LECARPENTIER, MBBS
Role: PRINCIPAL_INVESTIGATOR
EPS VILLE EVRARD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Eps Ville Evrard
Neuilly-sur-Marne, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
10477M-COQUILLE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.